Skip to content
eventVerified

FDA approved Descovy for HIV PrEP excluding receptive vaginal sex risk

Dated 3 October 2019: FDA approved Descovy for HIV PrEP excluding receptive vaginal sex risk. In the causal graph this event strengthens HIV/AIDS global response, a driver that strengthens Life expectancy at birth — an improving welfare path.

Who was responsible

Contribution type and responsibility level for each recorded actor — not sole-author shorthand.

No public contributors are listed for this fact.

What changed

Fact → Driver → Indicator. Relationship strength orders the paths; it is not the observed indicator movement.

Causal path

How this event connects to drivers and indicators in the graph.

  1. FactFDA approved Descovy for HIV PrEP excluding receptive vaginal sex risk
  2. strengthensDriverHIV/AIDS global response
  3. strengthensIndicatorLife expectancy at birth

Cite this page

Factrail. (2026). FDA approved Descovy for HIV PrEP excluding receptive vaginal sex risk. Factrail. https://factrail.ai/facts/fda-descovy-prep-approval-2019

https://factrail.ai/facts/fda-descovy-prep-approval-2019

Accessed 16 October 2026.

By the Factrail desk · Method: how we source and score · Last reviewed

Dispute this factNamed here, or represent someone who is? Request a right of reply.